EUVIMEDEUVIMED entdecken
Open Access

An immunotherapeutic artificial vitreous body hydrogel to control choroidal melanoma and preserve vision after vitrectomy

Muchao Chen iD, Jiaying Hu iD, Huiqin Gao iD, Jingjing Shen iD, Ting Wei iD, Jing Yao, Yan Zhang iD, Ping Gu iD, Zhuang Liu iD, Qian Chen iD

Science Advances · 03.11.2023 · 9 (44)

DOI: 10.1126/sciadv.adh1582 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, erschienen am 03.11.2023. Verfasst von Muchao Chen und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Functional Nano and Soft Materials (FUNSOM), Jiangsu Key Laboratory for Carbon Based Functional Materials and Devices, Soochow Universit…. Hauptthemen laut MEDLINE: Melanoma, Choroid Neoplasms. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Choroidal melanoma, a common intraocular malignant tumor, relies on local radiotherapy and enucleation for treatment. However, cancer recurrence and visual impairment remain important challenges. Here, a therapeutic artificial vitreous body (AVB) hydrogel based on tetra-armed poly(ethylene glycol) was developed to control the recurrence of choroidal melanoma and preserve vision after vitrectomy. AVB loaded with melphalan (Mel) and anti–programmed cell death ligand-1 (αPDL1), was injected after surgical resection in the choroidal melanoma mouse model. Afterwards, the sequentially released Mel and αPDL1 from AVB could achieve a synergistic antitumor effect to inhibit tumor recurrence. AVB with similar physical properties to native vitreous body could maintain the normal structure and visual function of eye after vitrectomy, which has been evidenced by standard examinations of ophthalmology in the mouse model. Thus, the immunotherapeutic AVB may be a promising candidate as an infill biomaterial to assist surgical treatment of intraocular malignant tumors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MelanomaChoroid NeoplasmsMelphalanVitrectomyImmunotherapyHydrogelsUveal NeoplasmsMiceNeoplasm Recurrence, LocalAnimalsVitreous BodyUveal Melanoma

Substanzen

HydrogelsMelphalan

Autor:innen und Institutionen

  • Institute of Functional Nano and Soft Materials (FUNSOM), Jiangsu Key Laboratory for Carbon Based Functional Materials and Devices, Soochow University, 199 Ren'ai Road, Suzhou, Jiangsu 215123, P.R. China.
  • Department of Ophthalmology, Ninth People's Hospital, Shanghai JiaoTong University School of Medicine, Shanghai 200011, P.R. China.
  • Shanghai Key Laboratory of Orbital Diseases and Ocular Oncology, Shanghai 200011, P.R. China.
  • Department of Ophthalmology and Vision Science, Eye & ENT Hospital, Shanghai Medical School, Fudan University, 83 Fenyang Road, Shanghai 200031, China.
  • Department of Orthopedics, Shanghai Yangpu Hospital Affiliated to Tongji University, Shanghai 200090, China.

ORCID-Profile: Muchao Chen, Jiaying Hu, Huiqin Gao, Jingjing Shen, Ting Wei, Yan Zhang, Ping Gu, Zhuang Liu, Qian Chen

Zitieren

APA

Chen, M., Hu, J., Gao, H., Shen, J., Wei, T., Yao, J., Zhang, Y., Gu, P., Liu, Z., & Chen, Q. (2023). An immunotherapeutic artificial vitreous body hydrogel to control choroidal melanoma and preserve vision after vitrectomy. Science Advances, 9(44). https://doi.org/10.1126/sciadv.adh1582

Vancouver

Chen M, Hu J, Gao H, Shen J, Wei T, Yao J, et al. An immunotherapeutic artificial vitreous body hydrogel to control choroidal melanoma and preserve vision after vitrectomy. Science Advances. 2023;9(44). doi:10.1126/sciadv.adh1582

BibTeX
@article{Chen2023,
  author = {Chen, Muchao and Hu, Jiaying and Gao, Huiqin and Shen, Jingjing and Wei, Ting and Yao, Jing and Zhang, Yan and Gu, Ping and Liu, Zhuang and Chen, Qian},
  title = {An immunotherapeutic artificial vitreous body hydrogel to control choroidal melanoma and preserve vision after vitrectomy},
  journal = {Science Advances},
  year = {2023},
  volume = {9},
  number = {44},
  doi = {10.1126/sciadv.adh1582}
}
Kostenlos starten →